Perioperative Evaluation of Immuno-inflammatory Parameters
This study consists of evaluations, using blood tests, various immune, inflammatory and coagulation parameters in the perioperative settings (different substudies), without changing anything to what is expected.
This will allow us to clarify the possible impact of surgery and analgesia on perioperative activation of these pathways.
研究概览
详细说明
A significant number of published data can be concluded that surgery and anesthetic and analgesic techniques have an impact on immunity and inflammation.
However, none of these studies have been performed with modern techniques, much more reliable evaluation of immune activity, such as the assessment of monocytic degranulation by flow cytometry.
It is therefore important to document immune activity using these new techniques, our patients, perioperative. This will be analyzed, so observational, the potential impact of different therapeutic interventions the patient receives.
This study consists of evaluations, using blood tests, various immune, inflammatory and coagulation parameters in the perioperative settings (different substudies), without changing anything to what is expected.
This will allow us to clarify the possible impact of surgery and analgesia on perioperative activation of these pathways.
研究类型
注册 (实际的)
联系人和位置
学习地点
-
-
-
Brussels、比利时、1200
- Cliniques universitaires Saint-Luc
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
描述
Inclusion Criteria:
- Surgical patients (and controls)
Exclusion Criteria:
- Immune disorders
学习计划
研究是如何设计的?
设计细节
队列和干预
团体/队列 |
|---|
|
Surgical cancer patients
No modification of the treatment
|
|
Non-surgical cancer patients
No modification of the treatment
|
|
Surgical non-cancer patients
No modification of the treatment
|
|
Non-surgical non-cancer patients
No modification of the treatment
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Immune parameters (immunocytes phenotype)
大体时间:baseline up to 8 days (return to baseline)
|
Function tests and surface markers
|
baseline up to 8 days (return to baseline)
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Long term outcome
大体时间:5 years
|
General morbidity and mortality
|
5 years
|
|
Coagulation parameters (like platelet function) (substudy)
大体时间:perioperative period (up to 3 days)
|
Function tests and surface markers
|
perioperative period (up to 3 days)
|
|
Inflammatory markers (cytokines) (substudy)
大体时间:baseline up to 8 days (return to baseline)
|
Intracellular FACS and ELISA measures
|
baseline up to 8 days (return to baseline)
|
合作者和调查者
调查人员
- 首席研究员:Patrice Forget, M.D.、UCL
研究记录日期
研究主要日期
学习开始
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.